Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RVPH will decline by -60.10% over the next 2 Weeks and hit $0.35 by Thursday, May 14, 2026. In that time frame, RVPH's share price is expected to range between $0.00 and $1.04.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 0.00 | 0.00 | 0.62 |
| May 13, 2026 | 0.00 | 0.02 | 0.67 |
| May 12, 2026 | 0.00 | 0.04 | 0.76 |
| May 11, 2026 | 0.00 | 0.10 | 0.78 |
| May 8, 2026 | 0.00 | 0.00 | 0.59 |
| May 7, 2026 | 0.00 | 0.16 | 0.84 |
| May 6, 2026 | 0.00 | 0.24 | 0.88 |
| May 5, 2026 | 0.00 | 0.26 | 0.93 |
| May 4, 2026 | 0.00 | 0.32 | 1.04 |
| May 1, 2026 | 0.00 | 0.12 | 0.78 |
RVPH shares rose +1.08% in Friday, May 1, 2026's trading session, rising from a previous close of $0.87 to move at $0.88. The stock demonstrated notable intraday movement (see RVPH's key stats for a full breakdown), fluctuating between $0.85 and $0.89, a +3.89% trading range. While recent weeks have seen some volatility, RVPH has managed to secure a +0.68% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 242.8K shares changing hands, 5.55K more than the previous session. This amounted to $213.64K in total market activity.
Will RVPH Continue Its Downward Trend?
According to analyst ratings and projections for RVPH, Reviva Pharmaceuticals Holdings, Inc. shares are anticipated to decrease by -42.53%, potentially reaching $0.62 per share by May 14, 2026. Short-term technical indicators for RVPH currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the RVPH stock forecast, now is not the best time to buy RVPH stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on RVPH covering social and institutional perspectives.
RVPH Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RVPH's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 30.93% to 40.43%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 37.75%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 42.77%, maintains a neutral outlook for the long term. Insights into RVPH's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Reviva Pharmaceuticals Short-Term Forecasts
RVPH Forecast For Next 5 Days
Our algorithm anticipates Reviva Pharmaceuticals (RVPH) stock could hit $0.04 by May 11, 2026. This represents a -95.04% rise from today's price, following a +3.94% change over the past five days.
RVPH Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.03, which would mean a -96.59% decrease from the current price of $0.88. Projections for this period range from a high of $0.58 to a low of $0.00.
RVPH Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Reviva Pharmaceuticals's price over the next three months point to a rise. RVPH stock is expected to peak at $9.33 on May 06, 2026 before potentially dipping to $1.01 on Jun 10, 2026. On average, RVPH is likely to trade around $4.04 in the coming 90 days.
Reviva Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Reviva Pharmaceuticals (RVPH) is expected to trade between $0.00 and $9.33 throughout 2026. This would result in an average price of $3.08, potentially offering investors a +250.04% return from current levels.
Reviva Pharmaceuticals Holdings, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is positioned to show a strong performance in May 2026. The price is predicted to move between $1.52 and $9.33, settling at an average of $5.63. This could translate to a +539.85% gain.
June 2026
Based on current market signals, Reviva Pharmaceuticals Holdings, Inc. is projected to trend june 2026. We forecast a trading range from $1.01 to $5.65, with a likely average price of $3.28. Investors could expect a potential return of +272.77%.
July 2026
Our predictive algorithms indicate Reviva Pharmaceuticals Holdings, Inc. stock may see a shift in July 2026. The expected range spans $1.14–$5.92, with an average target of $3.46. This represents a positive outlook and a possible gain of +293.23%.
August 2026
Analyzing established trends, Reviva Pharmaceuticals Holdings, Inc. looks set to move in August 2026. Projections place the stock between $0.59 and $5.22, averaging around $3.05. This suggests a +246.63% gain from current levels.
September 2026
Market indicators suggest Reviva Pharmaceuticals Holdings, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.46 to $5.82, with a midpoint forecast of $3.24. The stock might deliver a +268.22% gain.
October 2026
Forecasting for October 2026, models estimate that Reviva Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $5.16, averaging $2.28. This signals a positive trajectory with potential returns around +159.12%.
November 2026
According to our latest forecast models, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $3.95, settling at an average of $1.75. This could translate to a +98.89% gain.
December 2026
Based on current market signals, Reviva Pharmaceuticals Holdings, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $3.78, with a likely average price of $2.15. Investors could expect a potential return of +144.35%.
January 2027
Our predictive algorithms indicate Reviva Pharmaceuticals Holdings, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$3.60, with an average target of $2.16. This represents a positive outlook and a possible gain of +145.48%.
February 2027
Analyzing established trends, Reviva Pharmaceuticals Holdings, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $2.90, averaging around $2.03. This suggests a +130.71% gain from current levels.
March 2027
Market indicators suggest Reviva Pharmaceuticals Holdings, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $2.18, with a midpoint forecast of $1.32. The stock might deliver a +50.02% gain.
April 2027
Forecasting for April 2027, models estimate that Reviva Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.90, averaging $1.24. This signals a positive trajectory with potential returns around +40.93%.
RVPH's history of dividends and stock splits also plays a role in long-term investor confidence.